Praxis Precision Medicines (PRAX) Share-based Compensation (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Share-based Compensation of $12.9 million for Q1 2026, down 60.45% quarter-over-quarter from $32.7 million in Q4 2025.
Praxis Precision Medicines (PRAX) Share-based Compensation (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Share-based Compensation history runs 8 years deep, the most recent figure standing at $12.9 million for Q1 2026.
- In Q1 2026, Share-based Compensation changed N/A year-over-year to $12.9 million; the TTM figure through Mar 2026 stood at $46.9 million (up 430.8% YoY), while the FY2025 annual figure was $33.9 million, up 10919.81% from the prior year.
- Share-based Compensation for Q1 2026 stood at $12.9 million, down from $32.7 million in the prior quarter.
- The five-year high for Share-based Compensation was $32.7 million in Q4 2025, with the low at -$32.5 million in Q4 2024.
- The 5-year median for Share-based Compensation is $3.5 million (2024), against an average of $4.5 million.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation slumped 437.62% in 2022, then soared 1243100.0% in 2024.
- Praxis Precision Medicines' Share-based Compensation stood at -$22.0 million in 2022, then surged by 212.56% to $24.7 million in 2023, then tumbled by 231.35% to -$32.5 million in 2024, then jumped by 200.6% to $32.7 million in 2025, then slumped by 60.45% to $12.9 million in 2026.
- Business Quant data shows PRAX's Share-based Compensation at $12.9 million in Q1 2026, $32.7 million in Q4 2025, and $52000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Praxis Precision Medicines | 10.24 Bn | 9.48 Bn | - | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.31 Mn |
| Jun 30, 2026 | 11.31 Mn |
| Mar 31, 2026 | 12.92 Mn |
| Mar 31, 2026 | 12.92 Mn |
| Dec 31, 2025 | 32.67 Mn |
| Dec 31, 2025 | 32.67 Mn |
| Sep 30, 2025 | 52,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Dec 31, 2024 | -32.48 Mn |
| Dec 31, 2024 | -32.48 Mn |
| Sep 30, 2024 | 12.43 Mn |
| Sep 30, 2024 | 12.43 Mn |
| Jun 30, 2024 | 5.88 Mn |
| Jun 30, 2024 | 5.88 Mn |
| Mar 31, 2024 | 14.48 Mn |
| Mar 31, 2024 | 14.48 Mn |
| Dec 31, 2023 | 24.73 Mn |
| Dec 31, 2023 | 24.73 Mn |